Cognitive behavioural therapy in the treatment of chronic daily headache

Cover Page

Abstract

There is a high prevalence of chronic daily headache (CDH) in Russia. CDH is most often represented by chronic migraine or chronic tension headache, with an interdisciplinary approach using cognitive behavioural therapy (CBT) being effective in its treatment. Two clinical cases of CDH are presented: a female patient 38 years old with chronic migraine and a female patient 53 years old with chronic tension headache. Interdisciplinary treatment, including CBT, allowed a relatively rapid (within 3 months) and persistent (for 5 years) improvement to be achieved for both the headache and the recovery of functional activity in patients. The practical aspects of using CBT are presented. The efficacy of CBT in clinical practice and the feasibility of the widespread introduction of CBT for CDH are discussed.

About the authors

Veronika A. Golovacheva

Sechenov Moscow First State Medical University (Sechenov University), Moscow

Author for correspondence.
Email: platonova@neurology.ru
Russian Federation

Vladimir A. Parfenov

Sechenov Moscow First State Medical University (Sechenov University), Moscow

Email: platonova@neurology.ru
Russian Federation

References

  1. Halker R.B., Hastriter E.V., Dodick D.W. Chronic daily headache: an evidence-based and systematic approach to a challenging problem. Neurology 2011; 76: 37–43. doi: 10.1212/WNL.0b013e31820d5f32. PMID: 21321350.
  2. Magnusson J.E., Riess C.M., Becker W.J. Effectiveness of multidisciplinary treatment program for chronic daily headache. Can J Neurol Sci 2004; 31: 72–79. PMID: 15038474.
  3. Silberstein S. Chronic daily headache. J Am Osteopath Assoc 2005; 105: 23–29. PMID: 15928350.
  4. Steiner T.J., Stovner L.J., Katsarava Z. et al. The impact of headache in Europe: principal results of the Eurolight project. J Headache Pain 2014; 15: 31. doi: 10.1186/1129-2377-15-31. PMID: 24884549.
  5. Burch R.C., Loder S., Loder E. et al. The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies. Headache 2015; 55: 21–34. doi: 10.1111/head.12482. PMID: 25600719.
  6. Ayzenberg I., Katsarava Z., Sborowski A. et al. The prevalence of primary headache disorder in Russia: a countrywide survey. Cephalalgia 2012; 32: 373–381. doi: 10.1177/0333102412438977. PMID: 22395797.
  7. Azimova Yu.E., Sergeev A.V., Osipova V.V., Tabeeva G.R. [Diagnosis and treatment of headaches in Russia: the results of a questionnaire survey of doctors]. Rossijskij zhurnal boli 2010; (3, 4): 12–17. (In Russ.)
  8. Lyngberg A.C., Rasmussen B.K., Jørgensen T., Jensen R. Incidence of primary headache: a Danish epidemiologic follow-up study. Am J Epidemiol 2005; 161: 1066–1073. doi: 10.1093/aje/kwi139. PMID: 15901627.
  9. Stovner L.J., Hagen K., Jensen R. et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007; 27: 193–210. doi: 10.1111/j.1468-2982.2007.01288.x. PMID: 17381554.
  10. Kondrat'ev A.V., Shul'min A.V., Shnayder N.A., Lomakin A.I. [Headache as a medical and social problem (literature review)]. Nevrologiya, neyropsikhiatriya, psikhosomatika 2017; 9(2): 83–88. (In Russ.)
  11. Katsarava Z., Manack A., Yoon M.S. et al. Chronic migraine: classification and comparisons. Cephalalgia 2011; 31: 520–529. doi: 10.1177/0333102410383590. PMID: 21220376.
  12. Katsarava Z., Muessig M., Dzagnidze A. et al. Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia 2005; 25: 12–15. doi: 10.1111/j.1468-2982.2004.00789.x. PMID: 15606564.
  13. Golovacheva V.A., Parfenov V.A., Golovacheva A.A. [Cognitive complaints and disorders in patients with chronic daily headache ]. Nevrologiya, neyropsikhiatriya, psikhosomatika 2017; 9(4): 55–59. (In Russ.)
  14. Golovacheva V.A., Pozhidaev K.A., Golovacheva A.A. [Cognitive impairment in patients with migraine: causes, principles of effective prevention and treatment]. Nevrologiya, neyropsikhiatriya, psikhosomatika 2018; 10(3): 141–149. (In Russ.)
  15. Green M.W., Muskin P.R. The neuropsychiatry of headache. Cambridge, 2013. 169 p.
  16. Shagbazyan A.E., Sergeev A.V., Evdokimova E.M. et al. [The role of emotional and behavioral disorders in the formation of drug dependence in patients with drug-induced headache] Nevrologiya, neyropsikhiatriya, psikhosomatika 2016; 8(3): 76–81.(In Russ.)
  17. Evers S., Marziniak M. Clinical features, pathophysiology and treatment of medication-overuse headache. Lancet Neurol 2010; 9: 391–401. doi: 10.1016/S1474-4422(10)70008-9. PMID: 20298963.
  18. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 3nd Edition (ICHD-3 beta). Cephalalgia 2013; 33; 629–808. doi: 10.1177/0333102413485658. PMID: 23771276.
  19. Ayzenberg I., Katsarava Z., Sborowski A. et al. Headache-attributed burden and its impact on productivity and quality of life in Russia: structured health care for headache is urgently needed. Eur J Neurol 2014; 21: 758–765. doi: 10.1111/ene.12380. PMID: 24520863.
  20. Golovacheva V.A., Parfenov V.A., Tabeeva G.R. et al. [Optimizing the management of patients with chronic daily headache]. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 2017; 117(2): 4–9. (In Russ.)
  21. Lebedeva E.R., Gurariy N.M., Olesen Es. [Diagnostic criteria for transient ischemic attack]. Nevrologiya, neyropsikhiatriya, psikhosomatika 2018; 10(2): 12–19. (In Russ.)
  22. Maizels M. The patient with daily headaches. Am Fam Physician 2004; 70: 2299–2306. PMID: 15617293.
  23. Skorobogatykh K.V., Azimova Yu. E. [Comparative evaluation of the effectiveness of a combination of sumatriptan and dexketoprofen and sumatriptan monotherapy in the treatment of migraine attacks]. Nevrologiya, neyropsikhiatriya, psikhosomatika 2018; 10(3): 42–47. (In Russ.)
  24. Gaul C., Visscher C.M., Bhola R. et al. Team players against headache: multidisciplinary treatment of primary treatment of primary headaches and medication overuse headache. J Headache Pain 2011; 12: 511–519. doi: 10.1007/s10194-011-0364-y. PMID: 21779789.
  25. Nash J.M., Elyse R.P., Walker B.B. et al. Cognitive-behavioral group treatment for disabiling headache. Pain Med 2004; 5: 178–186. doi: 10.1111/j.1526-4637.2004.04031.x. PMID: 15209972.
  26. Sun-Edelstein C., Mauskop A. Alternative headache treatments: nutraceuticals, behavioral and physical treatments. Headache 2011; 51: 469–483. doi: 10.1111/j.1526-4610.2011.01846.x. PMID: 21352222.
  27. Andrasik F. What does the evidence show? Efficacy of behavioural treatments for recurrent headache in adults. Neurol Sci 2007; 28(Suppl 2): S70–S77. doi: 10.1007/s10072-007-0754-8. PMID: 17508184.
  28. Gunreben-Stempfle B., Griessinger N., Lang E. et al. Effectiveness of an intensive multidisciplinary headache. Headache 2009; 49: 990–1000. doi: 10.1111/j.1526-4610.2009.01448.x. PMID: 19473281.
  29. Wallasch T.M., Angeli A., Kropp P. Outcomes of headache-specific cross-sectional multidisciplinary treatment program. Headache 2012; 52: 1094–1105. doi: 10.1111/j.1526-4610.2012.02189.x. PMID: 22703374.
  30. Wallasch T.-M., Kropp P. Multidisciplinary integrated headache care: a prospective 12-month follow-up observational study. J Headache Pain 2012; 13: 521–529. doi: 10.1007/s10194-012-0469-y. PMID: 22790281.
  31. Otis J.D. Managing chronic pain: a cognitive-behavioral therapy: therapist guide, 1st ed. N.Y., 2007. 114 p.
  32. Zeeberg P., Olesen J., Jensen R. et al. Efficacy of multidisciplinary treatment in a tertiary referral headache centre. Cephalalgia 2005; 25: 1159–1167. doi: 10.1111/j.1468-2982.2005.00980.x. PMID: 16305604.

Statistics

Views

Abstract: 621

PDF (Russian): 547

Article Metrics

Metrics Loading ...

Dimensions

PlumX


Copyright (c) 2019 Golovacheva V.A., Parfenov V.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies